Tariq Musa sold $256K of GH
Tariq Musa sold 1,951 shares of Guardant Health, Inc. (GH) at $131.16 ($0.26M total) on 2026-06-22 under a Rule 10b5-1 trading plan.
How this was made
The 30-second read
Why it matters
A director’s pre-arranged open-market sale is typically not a fundamental catalyst; it may slightly influence sentiment but rarely drives price on its own.
Market read
Traders may log the sale for insider-trading monitoring, but it is unlikely to change the near-term fundamental outlook.
What to watch
The filing does not reveal intent beyond the pre-arranged plan; without additional insider buys/sales context, signal-to-noise is low.
Background
The article is a SEC Form 4 insider transaction disclosure for Guardant Health, Inc.
Ticker impact
Guardant Health director Tariq Musa filed a Form 4 showing an open-market sale of 1,951 shares at $131.16 on 2026-06-22 under a 10b5-1 plan.
Low likelihood of a sustained price move solely from this filing.
The disclosure is a pre-arranged 10b5-1 open-market sale by a director; it does not indicate new fundamentals, guidance, or regulatory/operational events.
Market effects
Minimal; this is company-specific insider transaction data with no stated sector catalyst.
None indicated.
None indicated.
Counterpoint
Even 10b5-1 sales can coincide with private views on valuation; traders may still watch for follow-on insider selling clusters.
Key entities
- issuerGuardant Health, Inc.
Subject of the Form 4 insider transaction disclosure.
- insiderTariq Musa
Director who sold 1,951 shares under a Rule 10b5-1 plan.
